Celadon Pharmaceuticals (LSE:CEL) Pre-Tax Income : £-5.49 Mil (TTM As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Celadon Pharmaceuticals Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Celadon Pharmaceuticals's pretax income for the six months ended in Jun. 2024 was £-2.41 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2024 was £-5.49 Mil. Celadon Pharmaceuticals's pretax margin was -3,817.46%.

During the past 5 years, Celadon Pharmaceuticals's highest Pretax Margin was -4225.39%. The lowest was -239800.00%. And the median was -75491.67%.

Celadon Pharmaceuticals Pre-Tax Income Historical Data

The historical data trend for Celadon Pharmaceuticals's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celadon Pharmaceuticals Pre-Tax Income Chart

Celadon Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

-1.06

-4.80

-18.12

-7.52

Celadon Pharmaceuticals Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Pre-Tax Income	Get a 7-Day Free Trial					-13.46	-4.66	-4.44	-3.09	-2.41

Competitive Comparison of Celadon Pharmaceuticals's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Celadon Pharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Celadon Pharmaceuticals's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Celadon Pharmaceuticals's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Celadon Pharmaceuticals's Pre-Tax Income falls into.

Save Embed

;

Save Embed

;

Celadon Pharmaceuticals Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Celadon Pharmaceuticals's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-6.216	+	0	+	-0.598	+	0.032	+	-0.741
	=	-7.52

Celadon Pharmaceuticals's Pretax Income for the quarter that ended in Jun. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-2.324	+	0	+	-0.305	+	0.017	+	0.207
	=	-2.41

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-5.49 Mil.

Celadon Pharmaceuticals (LSE:CEL) Pre-Tax Income Explanation

Celadon Pharmaceuticals's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-2.405	/	0.063
	=	-3,817.46%

During the past 5 years, Celadon Pharmaceuticals's highest Pretax Margin was -4225.39%. The lowest was -239800.00%. And the median was -75491.67%.

Celadon Pharmaceuticals Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Celadon Pharmaceuticals's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Celadon Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

32-33 Cowcross Street, London, GBR, EC1M 6DF

Website

https://www.celadonpharma.co.uk

Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis. It operates only in the UK and has only one geographical area.

Celadon Pharmaceuticals Headlines

No Headlines